Rostrupride-MF Tablet
Marketer
Rostrumed Biotech Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Rostrupride-MF Tablet
DiaGlyce-Duo tablets are an antidiabetic medication, a dual-agent formulation for adult type 2 diabetes management. This medication helps regulate blood glucose. DiaGlyce-Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption should be avoided due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.
Uses of Rostrupride-MF Tablet
Managing type 2 diabetes
Major Benefits of Rostrupride-MF Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Rostrupride-MF Tablet with a meal.
Common Side effects of Rostrupride-MF Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Rostrupride-MF Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rostrupride-MF Tablets should be administered with food.
How Rostrupride-MF Tablet works:
Rostrupride-MF tablets contain glimepiride and metformin, two antidiabetic drugs. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Rostrupride-MF Tablet with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Rostrupride-MF Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Lactation and Rostrupride-MF tablets are incompatible; the medication poses a potential risk of infant toxicity.
DrivingCAUTION
Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Rostrupride-MF Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Rostrupride-MF Tablet use. Consult your physician. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Rostrupride-MF Tablets cautiously, potentially requiring dose modification. Consult a physician before use. For those with mild to moderate liver disease, initiate treatment with a low Rostrupride-MF Tablet dosage; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Rostrupride-MF Tablet :
Should you forget a Rostrupride-MF Tablet dose, ingest it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rostrupride-MF Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |



